Journal of Cutaneous Immunology and Allergy最新文献

筛选
英文 中文
Possible role of the collagen type I alpha 1–platelet-derived growth factor beta chain fusion gene in the development of dermatofibrosarcoma protuberans with fibrosarcomatous transformation I型胶原α1-血小板衍生生长因子β链融合基因在纤维肉瘤转化的皮肤纤维肉瘤隆突发展中的可能作用
IF 1
Journal of Cutaneous Immunology and Allergy Pub Date : 2023-01-24 DOI: 10.1002/cia2.12297
Fuminori Katsumata MD, Koji Kamiya MD, PhD, Hitomi Miyauchi BEng, Hirofumi Okada MD, Atsuko Sato MD, PhD, Takeo Maekawa MD, PhD, Mayumi Komine MD, PhD, Mamitaro Ohtsuki MD, PhD
{"title":"Possible role of the collagen type I alpha 1–platelet-derived growth factor beta chain fusion gene in the development of dermatofibrosarcoma protuberans with fibrosarcomatous transformation","authors":"Fuminori Katsumata MD,&nbsp;Koji Kamiya MD, PhD,&nbsp;Hitomi Miyauchi BEng,&nbsp;Hirofumi Okada MD,&nbsp;Atsuko Sato MD, PhD,&nbsp;Takeo Maekawa MD, PhD,&nbsp;Mayumi Komine MD, PhD,&nbsp;Mamitaro Ohtsuki MD, PhD","doi":"10.1002/cia2.12297","DOIUrl":"10.1002/cia2.12297","url":null,"abstract":"<p>Dermatofibrosarcoma protuberans with fibrosarcomatous transformation (DFSP-FS) is a rare variant, with higher rates of recurrence and metastasis than DFSP. Detection of the collagen type I alpha 1 (COL1A1)–platelet-derived growth factor beta chain (PDGFB) fusion gene is useful for the diagnosis of DFSP. In this letter, we report a case of DFSP-FS, focusing on the expression of the COL1A1-PDGFB fusion gene in the lesions. Increased expression of the COL1A1-PDGFB fusion gene may be associated with fibrosarcomatous changes during the pathogenesis of DFSP.</p>","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12297","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43550088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severity and intractableness of skin infections caused by Panton–Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus 潘通-瓦伦丁白细胞素阳性耐甲氧西林金黄色葡萄球菌引起的皮肤感染的严重程度和难治性
IF 1
Journal of Cutaneous Immunology and Allergy Pub Date : 2023-01-19 DOI: 10.1002/cia2.12294
Tamihiro Kawakami MD, PhD, Kae Yokoyama MD, Takaharu Ikeda MD, PhD, Hiroshi Kaneko MD, PhD, Yuji Watanabe PhD, Hidemasa Nakaminami MD, PhD
{"title":"Severity and intractableness of skin infections caused by Panton–Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus","authors":"Tamihiro Kawakami MD, PhD,&nbsp;Kae Yokoyama MD,&nbsp;Takaharu Ikeda MD, PhD,&nbsp;Hiroshi Kaneko MD, PhD,&nbsp;Yuji Watanabe PhD,&nbsp;Hidemasa Nakaminami MD, PhD","doi":"10.1002/cia2.12294","DOIUrl":"10.1002/cia2.12294","url":null,"abstract":"<p>Cases of skin infections caused by Panton–Valentine leukocidin (PVL)-positive methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), particularly USA300 clone, have been increasing in Japan. We report that clinical findings of 5 patients with PVL-positive MRSA and compared to those of four patients with PVL-negative MRSA. Severities of patients with PVL-positive MRSA were significantly higher than those of patients with PVL-negative MRSA. Average durations of antimicrobial therapy for patients with PVL-positive MRSA were 3.4-fold longer than those for patients with PVL-negative MRSA. Our data suggest that PVL-positive MRSA should be deal with a causative agent for intractable skin infections in Japan likewise other countries.</p>","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12294","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41820687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of extensive alopecia areata following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine with favorable outcome 辉瑞- BioNTech BNT162b2 mRNA COVID - 19疫苗治疗广泛性斑秃1例,结果良好
IF 1
Journal of Cutaneous Immunology and Allergy Pub Date : 2023-01-15 DOI: 10.1002/cia2.12292
Yoshihiro Matsuda MD, Yoshio Kawakami MD, PhD, Masaya Kawamoto MD, Yoji Hirai MD, PhD, Shin Morizane MD, PhD
{"title":"A case of extensive alopecia areata following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine with favorable outcome","authors":"Yoshihiro Matsuda MD,&nbsp;Yoshio Kawakami MD, PhD,&nbsp;Masaya Kawamoto MD,&nbsp;Yoji Hirai MD, PhD,&nbsp;Shin Morizane MD, PhD","doi":"10.1002/cia2.12292","DOIUrl":"10.1002/cia2.12292","url":null,"abstract":"<p>The coronavirus disease 2019 (COVID-19) pandemic has an enormous impact on dermatological practice. There are many articles describing COVID-19-related and COVID-19 vaccine-related hair loss, such as telogen effluvium (TE), alopecia areata (AA), friction alopecia and anagen effluvium,<span><sup>1</sup></span> although their clinical outcomes have been poorly documented. We report a case of extensive AA following administration of the Pfzer-BioNTech BNT162b2 mRNA COVID-19 vaccine with favorable outcome.</p><p>A 37-year-old woman with no significant medical history except for childhood atopic dermatitis, developed persistent low-grade fever (37.2°C) on day +13 after the first dose of BNT162b2 mRNA vaccine (all date numbers refer to the first dose). Subsequently, the patient noticed coin-sized hair loss on day +22, and it became widespread within 1 week. Laboratory examinations performed at a nearby clinic on day +31 showed increased serum C-reactive protein (3.53 mg/dl) and decreased white blood cells (3000/μl) with 54.0% of neutrophils, 2.4% of eosinophils, and 34.8% of lymphocytes, whereas serological tests for syphilis were negative, and serum thyroid function tests, antinuclear antibody, immunoglobulin E, and thymus activation-regulated chemokine levels were all within normal ranges. She received the second dose BNT162b2 mRNA vaccine on day +32. The persistent low-grade fever spontaneously resolved on day +34 although the hair loss continued to aggravate. She presented to our hospital on day +73 for further evaluation. Physical examination revealed widespread alopecia with a severity of alopecia tool (SALT) II score of 80 (Figure 1A), whereas her eyebrows, eyelashes, and body hair were intact. Trichoscopy showed tapering hairs, broken hairs, black dots, and increase in vacant follicular ostia (Figure 1B). Histological findings of a skin biopsy revealed perifollicular lymphocytic infiltrate and increased number of telogen hairs (Figure 1C–E). Results of direct immunofluorescence studies were negative. We treated the patient with topical betamethasone butyrate propionate lotion. On day +120, the patient showed a sign of hair regrowth. The patient's hair mostly recovered leaving only one oval bald patch on day +310, and SALT II score decreased to 5 (Figure 1F).</p><p>The hair loss in this patient occurred following a febrile condition after the first dose of BNT162b2 mRNA vaccine, and we initially considered the patient as TE. However, initial onset with coin-sized hair loss and the presence of an oval bald patch in the late phase were rather characteristic for AA.</p><p>A review of the literature including the present case identified 17 cases of AA associated with COVID-19 vaccines.<span><sup>2-7</sup></span> Six cases had a previous history of AA. Types of vaccines prior to the development of AA included BNT162b2 mRNA in 11 cases, AZD1222/ChAdOx1 viral vector in three cases, and mRNA-1273 in three cases. In eight cases, AA appeared after the ","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12292","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48824335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skin Beautification with an ImmunatuRNA® Complex: A Natural Complex Based on Yeast RNA and Marine Derivatives on the Human Skin Immunity and Microbiome Composition 用ImmunatuRNA®复合物美化皮肤:一种基于酵母RNA和海洋衍生物的天然复合物,对人体皮肤免疫和微生物组组成有影响
IF 1
Journal of Cutaneous Immunology and Allergy Pub Date : 2023-01-01 DOI: 10.37191/mapsci-2582-6549-3(2)-039
V. Neymann
{"title":"Skin Beautification with an ImmunatuRNA® Complex: A Natural Complex Based on Yeast RNA and Marine Derivatives on the Human Skin Immunity and Microbiome Composition","authors":"V. Neymann","doi":"10.37191/mapsci-2582-6549-3(2)-039","DOIUrl":"https://doi.org/10.37191/mapsci-2582-6549-3(2)-039","url":null,"abstract":"The skin is the largest organ of human body implicated in vital physiological and immunological processes, including protection against injury, infections, and environmental exposures. Nevertheless, a number of negative external and internal factors, including increased pollution along with modern lifestyle can significantly influence on the skin immunity, promote aging and reduce regenerative capabilities. Cosmetic formulations based on natural ingredients, including plant and marine/algae extracts, and microbial-derived bio-actives may help to maintain healthy skin condition and protect its beautiful appearance.\u0000\u0000The ImmunatuRNA®* (*The trademark ImmunatuRNA® is a registered trademark in the European Union EUTM 018365297 and Great Britain UK00003630172. Any reference to the registration of the ImmunatuRNA® trademark applies to the designated territories), a signature complex (VRFD SA/VERDILAB Switzerland) based on the Natural RNA molecules obtained from yeasts, with added marine exopolysaccharides and natural hyaluronic acid with potential benefits for antibacterial and antiradical defense and maintaining skin detox homeostasis. Therefore, the main aim of this study is to experimentally assess the ImmunatuRNA® complex capabilities to enhance natural skin antioxidant defenses and protection against oxidative stress, by using human fibroblast cell culture. Additionally, this study will investigate the effects of the skincare products with added ImmunatuRNA® complex on the skin microbiome composition in the group of healthy adults with various skin types. The results obtained from the in vitro studies consistently demonstrated that treatment with an ImmunatuRNA® complex protects human fibroblasts against exposure to pro-oxidants, while at the same time enhances anti-oxidative defenses of these cells, demonstrated as reduced formation of free radicals and upregulation of SIRT-1 protein. Furthermore, the cosmetic intervention carried on the group of 10 healthy human volunteers with different skin types (oily, dry, combined, normal) aged between 23 and 65 years old demonstrated that using interchangeably of two cosmetic products-a Natural Moisturizer Probiotic Cream and Natural Detox Replenishing Face Mask containing the ImmunatuRNA® complex, for 4-weeks led to favorable changes in the composition of skin microbiome observed as a reduction of relative abundance of adverse microorganisms, previously linked to the skin inflammation and infections, such as Citrobacter koseri, Bacillus spp., Enterococcus spp., Alcaligenes spp., Pantoea spp. and Staphylococcus aureus. Based on following results, the use of skincare products containing the ImmunatuRNA® complex can help maintain a healthy skin microbiome while possibly preventing against infections and negative environmental exposures, in particularly against oxidative stress in healthy adults with all types of skin with age range 23-65 years old.","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82509793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usefulness of Gly m 4-specific IgE test in the diagnosis of Rosaceae fruit-oral allergy syndrome caused by Betulaceae pollen sensitization Gly-m4-特异性IgE检测对桦树科花粉致敏引起的蔷薇科果实口腔过敏综合征的诊断价值
IF 1
Journal of Cutaneous Immunology and Allergy Pub Date : 2022-12-09 DOI: 10.1002/cia2.12291
Tokiko Yoshida MD, Eishin Morita PhD, Yuko Chinuki PhD, Kunie Kohno PhD, Osamu Yamasaki PhD
{"title":"Usefulness of Gly m 4-specific IgE test in the diagnosis of Rosaceae fruit-oral allergy syndrome caused by Betulaceae pollen sensitization","authors":"Tokiko Yoshida MD,&nbsp;Eishin Morita PhD,&nbsp;Yuko Chinuki PhD,&nbsp;Kunie Kohno PhD,&nbsp;Osamu Yamasaki PhD","doi":"10.1002/cia2.12291","DOIUrl":"https://doi.org/10.1002/cia2.12291","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Pollen-food allergy syndrome (PFAS) is caused by the cross-reaction of the specific IgE to pollen allergens with similar allergens contained in fruits, vegetable, and nuts. The representative allergen responsible for this cross-reaction is pathogenesis-related protein (PR)-10. Specific IgE test using Gly m 4, soybean PR-10, is widely used to diagnose soy allergy. We aimed to investigate whether the Gly m 4-specific IgE test is useful for predicting oral allergy symptoms (OAS) to Rosaceae fruits in PFAS caused by Betulaceae pollen sensitization.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Forty-one patients with suspected PFAS were enrolled. Specific IgE levels were measured against alder pollen, apple, peach, pear, and Gly m 4, and correlation between test results and allergic symptoms was assessed to compare the accuracy of these allergen-specific IgE tests.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the 41 patients, 32 were positive for alder pollen-specific IgE. Of those, 16 showed OAS to at least one of apple, peach, and pear (OAS (+) group), and the rest 16 cases showed no symptoms (OAS (−) group). The Gly m 4-specific IgE value was significantly higher in the OAS (+) group (<i>p</i> = .014), and the highest in area under the receiver operating characteristics curve. The cut-off value for detection of the OAS (+) group was 2.65 UA/ml, with a sensitivity of 62.5% and a specificity of 81.3%. Other allergen-specific IgE values were not significantly different between the two groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>In the subjects sensitized to Betulaceae pollen allergens, the Gly m 4-specific IgE test is useful for predicting OAS of Rosaceae fruits.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12291","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50142340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usefulness of Gly m 4‐specific IgE test in the diagnosis of Rosaceae fruit‐oral allergy syndrome caused by Betulaceae pollen sensitization Gly - 4特异性IgE检测在诊断桦木科花粉致敏引起的玫瑰科水果口腔过敏综合征中的应用
IF 1
Journal of Cutaneous Immunology and Allergy Pub Date : 2022-12-09 DOI: 10.1002/cia2.12291
Tokiko Yoshida, E. Morita, Y. Chinuki, K. Kohno, O. Yamasaki
{"title":"Usefulness of Gly m 4‐specific IgE test in the diagnosis of Rosaceae fruit‐oral allergy syndrome caused by Betulaceae pollen sensitization","authors":"Tokiko Yoshida, E. Morita, Y. Chinuki, K. Kohno, O. Yamasaki","doi":"10.1002/cia2.12291","DOIUrl":"https://doi.org/10.1002/cia2.12291","url":null,"abstract":"Pollen‐food allergy syndrome (PFAS) is caused by the cross‐reaction of the specific IgE to pollen allergens with similar allergens contained in fruits, vegetable, and nuts. The representative allergen responsible for this cross‐reaction is pathogenesis‐related protein (PR)‐10. Specific IgE test using Gly m 4, soybean PR‐10, is widely used to diagnose soy allergy. We aimed to investigate whether the Gly m 4‐specific IgE test is useful for predicting oral allergy symptoms (OAS) to Rosaceae fruits in PFAS caused by Betulaceae pollen sensitization.","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51154560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two-sided influence of dupilumab on alopecia areata co-existing with severe atopic dermatitis: A case series and literature review dupilumab对伴有严重特应性皮炎的斑秃的双重影响:一个病例系列和文献综述
IF 1
Journal of Cutaneous Immunology and Allergy Pub Date : 2022-11-29 DOI: 10.1002/cia2.12289
Masahiro Fukuyama MD, PhD, Misaki Kinoshita-Ise MD, PhD, Yoshiko Mizukawa MD, PhD, Manabu Ohyama MD, PhD
{"title":"Two-sided influence of dupilumab on alopecia areata co-existing with severe atopic dermatitis: A case series and literature review","authors":"Masahiro Fukuyama MD, PhD,&nbsp;Misaki Kinoshita-Ise MD, PhD,&nbsp;Yoshiko Mizukawa MD, PhD,&nbsp;Manabu Ohyama MD, PhD","doi":"10.1002/cia2.12289","DOIUrl":"10.1002/cia2.12289","url":null,"abstract":"Alopecia areata (AA) often coexists with atopic dermatitis (AD). Recently, several reports suggested that dupilumab, an interleukin 4 receptor α‐antagonist, administration could be a promising medication not only for severe AD but also for AA concomitant with AD (AD‐AA). At the same time, dupilumab has also been reported to exacerbate AA in AD‐AA cases. Thus, the efficacy of dupilumab on AA in AD‐AA cases remains controversial.","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12289","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43315731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Targeting cytokines and potentiality of JAK–STAT inhibition in systemic sclerosis 系统性硬化症中JAK-STAT抑制的靶向细胞因子和潜力
IF 1
Journal of Cutaneous Immunology and Allergy Pub Date : 2022-11-28 DOI: 10.1002/cia2.12288
Wah Wah Aung MD, PhD, Yasuhito Hamaguchi MD, PhD, Takashi Matsushita MD, PhD
{"title":"Targeting cytokines and potentiality of JAK–STAT inhibition in systemic sclerosis","authors":"Wah Wah Aung MD, PhD,&nbsp;Yasuhito Hamaguchi MD, PhD,&nbsp;Takashi Matsushita MD, PhD","doi":"10.1002/cia2.12288","DOIUrl":"10.1002/cia2.12288","url":null,"abstract":"<p>Systemic sclerosis (SSc) or scleroderma is an autoimmune disease of unknown etiology, the treatment of which has garnered increased research interest. Associated symptoms range from localized or diffused skin tightening to multiple organ failure, including the lungs, kidneys, heart, and gastrointestinal tract, with considerable morbidity and mortality. Given that several cytokines contribute to the immune pathogenesis of SSc, efforts have been made toward the development of treatments targeting these cytokines to control disease progression. Indeed, anti-cytokine therapy has emerged as a new therapeutic intervention. Recently, the Janus kinase signal transducer and activator of transcription (JAK–STAT) pathway has been investigated as a novel candidate for the fibrogenic pathology of SSc. However, a comprehensive scientific review of the targeted therapy for SSc has been hampered by the rarity and heterogeneous nature of the disease. In this review, we provide an overview of cytokines involved in the innate and adaptive immune pathogenesis of SSc based on recent scientific data. In particular, we focus on targeted anti-cytokine therapy and the emerging role of the JAK–STAT inhibitor, a prospective therapeutic agent for the reversal of disease pathogenesis.</p>","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12288","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47744722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis B and C Co-Infection among HIV-Positive Patients Attending Art at General Hospital Kaltungo, Gombe State, Nigeria 在尼日利亚贡贝州Kaltungo综合医院接受Art治疗的艾滋病毒阳性患者中乙型和丙型肝炎合并感染
IF 1
Journal of Cutaneous Immunology and Allergy Pub Date : 2022-11-10 DOI: 10.37191/mapsci-2582-6549-3(2)-038
Danladi Nengak Precious
{"title":"Hepatitis B and C Co-Infection among HIV-Positive Patients Attending Art at General Hospital Kaltungo, Gombe State, Nigeria","authors":"Danladi Nengak Precious","doi":"10.37191/mapsci-2582-6549-3(2)-038","DOIUrl":"https://doi.org/10.37191/mapsci-2582-6549-3(2)-038","url":null,"abstract":"Background: HBV and HCV infection, have been found to worsen the health of PLWAS, thereby impairing treatments and management. HIV, HBV, and HCV are transmitted through similar routes and hence the presence of infection with any of them could be a risk factor for the others.\u0000\u0000Objective: Determine the prevalence of HBV/HCV co-infection in persons with HIV.\u0000\u0000Method: This was a serological study in persons with HIV. For HBV, the Hepatitis B surface antigen was investigated and the antibodies to HCV for HCV. The study included HIV-positive patients registered with the ART clinic at General Hospital Kaltungo, irrespective of age. Ethical approval was gotten, consent was received from patients, and patient’s information was kept confidential. Prevalence was determined by comparing the total positive test, to the overall study population tested.\u0000\u0000Results: A total of 170 HIV-positive individuals took part in the study. The study had 59 (34.7%) males with mean age (standard deviation) of 40.9 (11.4) years and 111 (65.3%) females, having a Mean (Standard Deviation) of 37.1 (11.0) years.\u0000\u0000The result revealed a statistically significant, high negative association between the viral load values of HIV, HBV and HCV co-infection and marital status (rs=-0.812, rs=-0.812, n=170, p=0.000, at α=0.001 significant level) with a 66% degree of variability. Also, the study observed a high positive, significant association within the viral loads of HIVHBV co-infection and HIVHCV co-infection (rs=-0.762, n=170, p=0.000, at α=0.001 significant level) with a 58% degree of variability using the Spearman correlation.\u0000\u0000Conclusion: Co-infection for HBV was higher than that of HCV. No co-infection with all three viruses was found in this study. This can improve the health and treatment of PLWAS, then screening them for both HBV and HCV, must become a part of the guidelines.","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76485740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Simultaneous infection in a couple by Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus related to the USA300 clone 一对夫妇同时感染与USA300克隆相关的Panton‐Valentine白细胞调素阳性的甲氧西林敏感金黄色葡萄球菌
IF 1
Journal of Cutaneous Immunology and Allergy Pub Date : 2022-10-31 DOI: 10.1002/cia2.12287
Takuo Murakami MD, Naohiko Aozasa MD, PhD, Yoshika Suzuki MD, Tomoka Togo MD, Kyohei Miyano MD, PhD, Hiroshi Kaneko, Hidemasa Nakaminami PhD, Yuichiro Tsunemi MD, PhD, Koichiro Nakamura MD, PhD
{"title":"Simultaneous infection in a couple by Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus related to the USA300 clone","authors":"Takuo Murakami MD,&nbsp;Naohiko Aozasa MD, PhD,&nbsp;Yoshika Suzuki MD,&nbsp;Tomoka Togo MD,&nbsp;Kyohei Miyano MD, PhD,&nbsp;Hiroshi Kaneko,&nbsp;Hidemasa Nakaminami PhD,&nbsp;Yuichiro Tsunemi MD, PhD,&nbsp;Koichiro Nakamura MD, PhD","doi":"10.1002/cia2.12287","DOIUrl":"10.1002/cia2.12287","url":null,"abstract":"<p>We present a case of Panton-Valentine leucocidin-positive methicillin-susceptible <i>Staphylococcus aureus</i> infection in a couple. The isolated bacterium was not methicillin-resistant but was very closely related to the USA300 clone.\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12287","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46641553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信